Takeda Dengue Vaccine Patent, Pregnant/Breastfeeding Use
Summary
Takeda Vaccines, Inc. has filed a patent application (US20260108594A1) covering the use of a dengue vaccine in pregnant and/or breastfeeding human subjects. The application, assigned to inventors Sheri Denet Klas, Hansi Dean, and Karissa Adkins, was published on April 23, 2026 with an original filing date of October 13, 2023. The patent covers a method of protecting against dengue disease in this specific patient population using a live attenuated dengue vaccine formulation.
“A dengue vaccine for use in a method of protecting against dengue disease in a pregnant and/or breastfeeding human subject.”
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 271 changes logged to date.
What changed
Takeda Vaccines, Inc. filed patent application US20260108594A1 with the USPTO, covering a dengue vaccine composition and method for protecting against dengue disease specifically in pregnant and/or breastfeeding human subjects. The application was published on April 23, 2026, with an original filing date of October 13, 2023, and assigns the invention to inventors Sheri Denet Klas, Hansi Dean, and Karissa Adkins.
Pharmaceutical companies developing or marketing dengue vaccines should monitor the prosecution of this application for potential freedom-to-operate concerns in the pregnant and breastfeeding population segment. Generic or biosimilar manufacturers may also wish to review any future issued claims for design-around opportunities or potential licensing discussions if the patent ultimately issues with broad coverage of this therapeutic use.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
USE OF DENGUE VACCINE IN PREGNANT AND/OR BREASTFEEDING SUBJECTS
Application US20260108594A1 Kind: A1 Apr 23, 2026
Assignee
Takeda Vaccines, Inc.
Inventors
Sheri Denet Klas, Hansi Dean, Karissa Adkins
Abstract
A dengue vaccine for use in a method of protecting against dengue disease in a pregnant and/or breastfeeding human subject.
CPC Classifications
A61K 39/12 A61K 47/10 A61K 47/26 A61K 47/42 A61P 37/04 C12N 7/00 A61K 2039/5254 A61K 2039/545 A61K 2039/55 A61K 2039/70 C12N 2770/24134 C12N 2770/24162 C12N 2770/24171
Filing Date
2023-10-13
Application No.
19120531
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.